Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898078112> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2898078112 abstract "The present study aimed to investigate the efficacy of five signaling pathway inhibitors, N-[N-(3,5‑difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester, vismodegib, salinomycin, ruxolitinib and stattic, as novel therapeutic agents that target breast cancer stem cells (BCSCs) in triple-negative breast cancer (TNBC). The in vitro anti-proliferative, anti-invasive, pro-apoptotic and inhibitory effects on BCSC self-renewal of these signaling pathway inhibitors on the TNBC stem cell line HCC38 were examined by MTT assays, Matrigel invasion assays, flow cytometry and suspension mammosphere assays, respectively. For the in vivo study, another TNBC stem cell line, HCC1806, pretreated with these signaling pathway inhibitors, was inoculated into female nonobese diabetic/severe combined immunodeficient mice, and the tumor volumes were measured following tumor formation. Treatment of HCC38 cells with each signaling pathway inhibitor significantly decreased TNBC cell proliferation, cell invasion and mammosphere formation while inducing cell apoptosis by inhibiting the protein expression or phosphorylation of downstream signaling molecules. In the xenograft mouse models, tumor formation and growth of HCC1806 cells pretreated with each signaling pathway inhibitor were effectively suppressed. Treatment with these signaling pathway inhibitors may provide a novel therapeutic strategy against TNBC by targeting BCSCs, thus providing promising insight for clinical applications in patients with TNBC." @default.
- W2898078112 created "2018-10-26" @default.
- W2898078112 creator A5006884460 @default.
- W2898078112 creator A5063447635 @default.
- W2898078112 creator A5066786495 @default.
- W2898078112 creator A5068584522 @default.
- W2898078112 creator A5077416476 @default.
- W2898078112 creator A5080936626 @default.
- W2898078112 date "2018-10-18" @default.
- W2898078112 modified "2023-09-22" @default.
- W2898078112 title "Signaling pathway inhibitors target breast cancer stem cells in triple-negative breast cancer" @default.
- W2898078112 doi "https://doi.org/10.3892/or.2018.6805" @default.
- W2898078112 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30365081" @default.
- W2898078112 hasPublicationYear "2018" @default.
- W2898078112 type Work @default.
- W2898078112 sameAs 2898078112 @default.
- W2898078112 citedByCount "20" @default.
- W2898078112 countsByYear W28980781122019 @default.
- W2898078112 countsByYear W28980781122020 @default.
- W2898078112 countsByYear W28980781122021 @default.
- W2898078112 countsByYear W28980781122022 @default.
- W2898078112 countsByYear W28980781122023 @default.
- W2898078112 crossrefType "journal-article" @default.
- W2898078112 hasAuthorship W2898078112A5006884460 @default.
- W2898078112 hasAuthorship W2898078112A5063447635 @default.
- W2898078112 hasAuthorship W2898078112A5066786495 @default.
- W2898078112 hasAuthorship W2898078112A5068584522 @default.
- W2898078112 hasAuthorship W2898078112A5077416476 @default.
- W2898078112 hasAuthorship W2898078112A5080936626 @default.
- W2898078112 hasBestOaLocation W28980781121 @default.
- W2898078112 hasConcept C121608353 @default.
- W2898078112 hasConcept C2778608917 @default.
- W2898078112 hasConcept C2780110267 @default.
- W2898078112 hasConcept C2780394083 @default.
- W2898078112 hasConcept C28328180 @default.
- W2898078112 hasConcept C502942594 @default.
- W2898078112 hasConcept C530470458 @default.
- W2898078112 hasConcept C54355233 @default.
- W2898078112 hasConcept C55427017 @default.
- W2898078112 hasConcept C62478195 @default.
- W2898078112 hasConcept C86803240 @default.
- W2898078112 hasConcept C95444343 @default.
- W2898078112 hasConceptScore W2898078112C121608353 @default.
- W2898078112 hasConceptScore W2898078112C2778608917 @default.
- W2898078112 hasConceptScore W2898078112C2780110267 @default.
- W2898078112 hasConceptScore W2898078112C2780394083 @default.
- W2898078112 hasConceptScore W2898078112C28328180 @default.
- W2898078112 hasConceptScore W2898078112C502942594 @default.
- W2898078112 hasConceptScore W2898078112C530470458 @default.
- W2898078112 hasConceptScore W2898078112C54355233 @default.
- W2898078112 hasConceptScore W2898078112C55427017 @default.
- W2898078112 hasConceptScore W2898078112C62478195 @default.
- W2898078112 hasConceptScore W2898078112C86803240 @default.
- W2898078112 hasConceptScore W2898078112C95444343 @default.
- W2898078112 hasLocation W28980781121 @default.
- W2898078112 hasLocation W28980781122 @default.
- W2898078112 hasOpenAccess W2898078112 @default.
- W2898078112 hasPrimaryLocation W28980781121 @default.
- W2898078112 hasRelatedWork W1966181922 @default.
- W2898078112 hasRelatedWork W1984892884 @default.
- W2898078112 hasRelatedWork W2025353166 @default.
- W2898078112 hasRelatedWork W2026669993 @default.
- W2898078112 hasRelatedWork W2032755404 @default.
- W2898078112 hasRelatedWork W2741545625 @default.
- W2898078112 hasRelatedWork W2756868900 @default.
- W2898078112 hasRelatedWork W2898078112 @default.
- W2898078112 hasRelatedWork W4361256953 @default.
- W2898078112 hasRelatedWork W4361256957 @default.
- W2898078112 isParatext "false" @default.
- W2898078112 isRetracted "false" @default.
- W2898078112 magId "2898078112" @default.
- W2898078112 workType "article" @default.